Matches in Wikidata for { <http://www.wikidata.org/entity/Q64725983> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q64725983 description "clinical trial" @default.
- Q64725983 description "ensayu clínicu" @default.
- Q64725983 description "klinisch onderzoek" @default.
- Q64725983 description "клінічне випробування" @default.
- Q64725983 name "Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders" @default.
- Q64725983 type Item @default.
- Q64725983 label "Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders" @default.
- Q64725983 prefLabel "Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders" @default.
- Q64725983 P1050 Q64725983-0EF3B6A1-03E5-42A2-A127-3F0F2F91CCA0 @default.
- Q64725983 P1132 Q64725983-543FDEFB-0156-4703-BC16-A25431FAC69A @default.
- Q64725983 P1476 Q64725983-347BE508-02B5-4793-A80A-37FEAFDF7564 @default.
- Q64725983 P17 Q64725983-875DFDF8-66A7-49FA-ABDD-943403F509B8 @default.
- Q64725983 P2899 Q64725983-6707BEF0-7E74-405A-AEC7-DD6395912C76 @default.
- Q64725983 P3098 Q64725983-B8471B5F-520E-4777-B53D-0C9EA30EC469 @default.
- Q64725983 P31 Q64725983-10CE2B8B-7142-48A3-A233-5E70F7A1A77F @default.
- Q64725983 P4135 Q64725983-9621885A-F5FA-4363-ABE2-AA9E4FA2E519 @default.
- Q64725983 P4844 Q64725983-D7438EC6-A5D9-4BCC-84D5-9CFD567EFD45 @default.
- Q64725983 P4844 Q64725983-FC70D3FE-99DE-42DF-A9D9-FF69497C7A30 @default.
- Q64725983 P580 Q64725983-BCA3FB23-357D-4597-8309-247F28B5A024 @default.
- Q64725983 P582 Q64725983-46A3203A-DECD-4249-BFD0-B66C8DCDF85C @default.
- Q64725983 P6099 Q64725983-7AA2EE88-519E-4499-8AB5-CA4BFE6E547D @default.
- Q64725983 P6153 Q64725983-F958957F-C28C-4C3C-9F90-CFA8D425ACCD @default.
- Q64725983 P8363 Q64725983-B92826DD-A51A-47B3-BA0E-0814B9E5C886 @default.
- Q64725983 P921 Q64725983-9A5A1C39-19C6-414C-8BD6-A71A29CD93A6 @default.
- Q64725983 P1050 Q1553850 @default.
- Q64725983 P1132 "+129" @default.
- Q64725983 P1476 "Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Treatment of Adult Patients (>18 Years) With Lymphohematopoietic Disorders" @default.
- Q64725983 P17 Q30 @default.
- Q64725983 P2899 "+18" @default.
- Q64725983 P3098 "NCT00587054" @default.
- Q64725983 P31 Q30612 @default.
- Q64725983 P4135 "+55" @default.
- Q64725983 P4844 Q185916 @default.
- Q64725983 P4844 Q416507 @default.
- Q64725983 P580 "2001-06-01T00:00:00Z" @default.
- Q64725983 P582 "2011-05-01T00:00:00Z" @default.
- Q64725983 P6099 Q42824440 @default.
- Q64725983 P6153 Q1808012 @default.
- Q64725983 P8363 Q78089383 @default.
- Q64725983 P921 Q954625 @default.